drugset / Trial / NCT07709598

Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Analgesia in Abdominal Surgery

NCT07709598

Phase 2/3 Recruiting 330 enrolled Shanghai Huilun Pharmaceutical Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This clinical trial is a multiple-center, randomized, double-blind, placebo- and active-controlled parallel-group Phase II/III clinical trial, to evaluate the efficacy and safety of HL-1186 Tablets for Postoperative Analgesia in Abdominal Surgery.

Timeline

Start
2026-05-11
Primary completion
2026-10
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject HL-1186 Unknown Oral
Comparator Oxycodone Other / unclassified Oral

Indications

No indication recorded.